Search Results 511-520 of 17271 for GLP-1 therapy
... treatment works better than the current standard therapy. ... 1 trial. Phase 4 trials look at long ... Note: Glucagon-like peptide-1 (GLP-1) receptor ...
... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 ... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy ...
... treatment works better than the current standard therapy. ... At the time of treatment with subprotocol specified therapy ... 1; female 1;; Age: 10 to < 13 years; ...
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.
Mayo Clinic doctors and therapists research prevention, diagnosis and treatment options for lymphedema. ... Had to reduce blood pressure meds due to GLP-1. Anyone ...
... treatment of recurrent Clostridium difficile infection (CDI). Enrolled subjects will receive one treatment with RBX2660 (microbiota suspension).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!